Pilot, open-label, randomised, crossover phase I study investigating the tolerability, pharmacokinetics and bioavailability of oral hydroxyprogesterone [LPCN 1107] vs intramuscular hydroxyprogesterone in healthy, non-pregnant volunteers
Phase of Trial: Phase I
Latest Information Update: 11 Mar 2015
Price : $35 *
At a glance
- Drugs Hydroxyprogesterone (Primary) ; Hydroxyprogesterone
- Indications Preterm labour
- Focus Adverse reactions; Pharmacokinetics
- 11 Mar 2015 Results presented at the Society for Maternal-Fetal Medicine 35th Annual Meeting, according to a Lipocine media release.
- 29 May 2014 New trial record
- 15 May 2014 Results published in a Lipocine media release.